Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.382NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.356ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.356ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.356ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.356NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.376ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.376ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.376ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.376NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.607ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.607ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.607ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.607NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.163ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.163ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.163ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.163NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.337ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.337ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.337ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.337NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.158ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.158ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.158ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.158NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.602ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.602ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.602ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.602NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.289ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.289ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.289ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.289NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.7.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.7.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDHORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDHNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.15.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.15.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used